TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Polyrizon Ltd. ( (PLRZ) ) is now available.
On December 5, 2025, Polyrizon Ltd. announced a securities purchase agreement with investors for the sale of 552,269 ordinary shares at $9.00 per share, exceeding Nasdaq’s minimum price requirements. The offering, expected to close on the same day, aims to raise approximately $4.97 million, which will be used for general corporate purposes, including operations, capital expenditures, and strategic opportunities. This move is expected to bolster Polyrizon’s financial standing and support its growth initiatives in the biotechnology industry.
More about Polyrizon Ltd.
Polyrizon Ltd. operates in the biotechnology sector, focusing on developing innovative solutions for the protection of biological systems against biological threats and allergens. The company is based in Raanana, Israel, and is engaged in technology development and strategic acquisitions to enhance its market position.
Average Trading Volume: 3,124,210
Technical Sentiment Signal: Sell
Current Market Cap: $14.47M
Learn more about PLRZ stock on TipRanks’ Stock Analysis page.